B. Metzler Seel. Sohn & Co. Holding Ag Insmed Inc Call Options Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INSM
# of Institutions
466Shares Held
174MCall Options Held
5.21MPut Options Held
5.09M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.2MShares$853 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$458 Million0.09% of portfolio
-
State Street Corp Boston, MA4.66MShares$327 Million0.01% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.5B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...